The UB Center for Integrated Global Biomedical Sciences will partner with Charlotte’s Web Labs on a research initiative to advance understanding of the therapeutic uses of cannabinoids.
A study led by a UB pediatric endocrinologist has found that a drug currently on the market for other autoimmune conditions can preserve the beta cells of children and young adults recently diagnosed with Type 1 diabetes.
Research reveals the details of how salivary glands collectively produce the constellation of proteins found in saliva, opening the door to important medical research.
Western New Yorkers who were recently exposed to a household member who has tested positive for COVID-19 now have an opportunity to be treated with a promising drug being investigated for COVID-19 infection.
UB research is helping to define the best time to give a specific treatment to infants born with Krabbe disease. This treatment has been found to prolong life for these infants, for as long as a few years.
A rare, debilitating condition in pregnancy that causes nausea and vomiting so severe that some women end up terminating their pregnancies can be effectively treated with the seizure drug gabapentin.
The UB Center for Integrated Global Biomedical Sciences will partner with Àvida Biotech to advance new antivirals and vaccines for neglected infectious diseases such as the dengue, Zika and Chikungunya viruses.